RxDoctor Payments Data

Lyndsay Claroni, DO

Family Medicine · Dallas, GANPI 1861785073

Payments from drug & device makers

$579in general payments, 2019–2025

Across 34 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$210
  • Novo Nordisk$83
  • Lilly USA, LLC$38
  • Takeda Pharmaceuticals U.S.A., Inc.$37
  • Sanofi-aventis U.S. LLC$32
  • Dynavax Technologies Corporation$26
  • plus $153 from 9 others

What the payments were for

  • Food & beverage$579100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$579 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$32,763
Medicare patients
141
Services billed
561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate28$39,773
TrulicityDulaglutide18$24,800
MounjaroTirzepatide13$21,984
JardianceEmpagliflozin16$13,757
EliquisApixaban15$10,903
Breo ElliptaFluticasone/Vilanterol16$6,443
Spiriva RespimatTiotropium Bromide12$6,178
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$5,151
Albuterol Sulfate HfaAlbuterol Sulfate90$3,164
ShingrixVaricella-Zoster Ge/As01b/Pf13$2,879
Fenofibrate38$2,746
SynthroidLevothyroxine Sodium15$1,926
Pravastatin Sodium177$1,912
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,699
Atorvastatin Calcium220$1,693

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$38$46,78531 claims
PfizerEliquis$20$10,90315 claims
GSKBreo Ellipta, Shingrix$16$9,32129 claims
AbbVieSynthroid$17$1,92615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Dallas

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →